Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients

BACKGROUND: PSMA-targeted radioligand therapy (PSMA-RLT) yielded impressive results in the metastasized castration-resistant prostate carcinoma (mCRPC) setting. High expression of PSMA is essential for successful PSMA-RLT. However, some patients develop [(18)F]FDG-avid lesions with low or no PSMA ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosar, Florian, Ribbat, Kalle, Ries, Martin, Linxweiler, Johannes, Bartholomä, Mark, Maus, Stephan, Schreckenberger, Mathias, Ezziddin, Samer, Khreish, Fadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246282/
https://www.ncbi.nlm.nih.gov/pubmed/32449086
http://dx.doi.org/10.1186/s13550-020-00640-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246282/
https://www.ncbi.nlm.nih.gov/pubmed/32449086
http://dx.doi.org/10.1186/s13550-020-00640-2

Ejemplares similares